Page 12 - Nasdaq Podd News Today

Insulet (NASDAQ:PODD – Get Rating) had its target price lifted by BTIG Research from $340.00 to $350.00 in a research report released on Monday morning, The Fly reports. The firm currently has a buy rating on the medical instruments supplier’s stock. A number of other equities research analysts have also weighed in on the company. […]

Insulet (NASDAQ:PODD – Get Rating) had its price objective lifted by Stifel Nicolaus from $300.00 to $342.00 in a report published on Thursday, The Fly reports. The brokerage currently has a hold rating on the medical instruments supplier’s stock. Other analysts have also issued reports about the company. Morgan Stanley boosted their target price on […]

Congress Wealth Management LLC DE increased its holdings in Insulet Co. (NASDAQ:PODD – Get Rating) by 10.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,396 shares of the medical instruments supplier’s stock after purchasing an additional 624 shares during the […]

New York State Common Retirement Fund grew its holdings in Insulet Co. (NASDAQ:PODD – Get Rating) by 6.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 95,353 shares of the medical instruments supplier’s stock after acquiring an additional 5,424 shares during the period. […]

Riverstone Advisors LLC cut its position in Insulet Co. (NASDAQ:PODD – Get Rating) by 6.7% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 15,087 shares of the medical instruments supplier’s stock after selling 1,086 shares during the quarter. Insulet accounts for 3.1% of Riverstone Advisors LLC’s investment portfolio, making the stock its […]

Shares of Insulet Co. (NASDAQ:PODD – Get Rating) have been assigned a consensus recommendation of “Moderate Buy” from the fourteen ratings firms that are covering the firm, Marketbeat reports. Five investment analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price objective […]

Insulet Co. (NASDAQ:PODD – Get Rating) has been assigned a consensus rating of “Moderate Buy” from the fourteen research firms that are currently covering the company, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12 month target […]

Insulet Co. (NASDAQ:PODD – Get Rating) CFO Wayde D. Mcmillan sold 1,255 shares of the stock in a transaction dated Monday, April 3rd. The stock was sold at an average price of $318.31, for a total transaction of $399,479.05. Following the completion of the transaction, the chief financial officer now directly owns 22,865 shares of […]

AMF Tjanstepension AB lessened its holdings in Insulet Co. (NASDAQ:PODD – Get Rating) by 5.8% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 25,938 shares of the medical instruments supplier’s stock after selling 1,590 shares during the period. AMF Tjanstepension AB’s holdings in Insulet were worth $7,636,000 […]

Oak Ridge Investments LLC raised its stake in shares of Insulet Co. (NASDAQ:PODD – Get Rating) by 1.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,070 shares of the medical instruments supplier’s stock after acquiring an additional 144 […]